China NMPA Drug Inspection - Jiangsu Pingguang Pharmaceutical (Jiaozuo) Co., Ltd. - Norfloxacin capsules
China NMPA drug inspection for Jiangsu Pingguang Pharmaceutical (Jiaozuo) Co., Ltd. published September 21, 2020. Drug: Norfloxacin capsules. On September 21, 2020, the Jiangxi Provincial Drug Administration published its fourth inspection report of the year, id
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jiangsu Pingguang Pharmaceutical (Jiaozuo) Co., Ltd. published September 21, 2020. Drug: Norfloxacin capsules. On September 21, 2020, the Jiangxi Provincial Drug Administration published its fourth inspection report of the year, id
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox